Review: biostimulants for sustainable crop production
This book is what a review should be all about: lengthy (365 pg), thorough, several tables and hundreds of references. Overall, this is a complete book on a highly relevant topic. Biostimulants: natural substances supporting vegetative growth, uptake of nutrients, tolerance to abiotic stress by roots and plant tolerance to drought and salt stress. Feeding
European generic medicines production after corona
Biomedicines are coming
The major pharmaceutical industry is going through a difficult time. Industry should find a new track. Biomedicines could open up a new chapter. This is the third of four articles on the pharmaceutical industry. Biomedicines, yes or no? For over 20 years, biotechnology and gene therapy have hold the promise of determining the future of
New superpowers in the pharmaceutical industry?
The major pharmaceutical industry (big pharma) is going through a difficult time. Industry needs to come on track again. Can the new superpowers India and China lead the way? This is the second of four articles on the pharmaceutical industry. Pharmaceutical industry relocated to India and China Nowadays, India and China are the major producers
Has big pharma lost track?
Major pharmaceutical companies (big pharma) are having a difficult time. Shareholders complain about falling profit margins; governments, insurance companies and patients complain about sky-high medicine prices. Industry should find a new direction – but which one? This is the first of four articles about the pharmaceutical industry. Big pharma’s old model has become obsolete The
Corona pandemic and energy transition
Will the corona pandemic speed up the energy transition? The question is much debated. Those who would like to accelerate the transition seem to have the upper hand, if we can judge by the headlines of the news. Fine particulate matter and corona pandemic We can add a new argument to this discussion. For there
New antibiotics – their development stagnates. Why?
Resistance to antibiotics is a growing problem; and yet, the development of new antibiotics stagnates. Why? Don’t we need new antibiotics, on second thoughts? Or does industry judge that new developments will not earn them enough money? New antibiotics from nature Recently, we ran an article on the avoidance of resistance by leaf-cutting ants in



















There is no such thing as an individual
Modern biologists are waging a fierce debate on the meaning of the concept of the individual. Definitions of well-known phenomena like symbiosis and parasitism need to be rephrased. The debate goes beyond the world of plants and micro-organisms; the subject of the discussion includes mammals and therefore also mankind. We know for a long time
on: 26 November 2020